Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Upholds Patent Claims by Genetic Technologies

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has received an ex parte re-examination certificate from the US Patent and Trademark Office for certain claims related to the company's non-coding DNA patent.

The certificate was issued for the ex parte re-examination of claims 1-18 and 26-32 of US Patent No. 5,612,179 based on a request for re-examination of the claims in April from Merial. GTG is suing Duluth, Ga.-based Merial, alleging infringement of the '179 patent.

In March, USPTO affirmed the validity of certain claims of the patent, but did not re-examine other claims, and as a result, Merial asked USPTO to re-examine claims 1-18 and 26-32 of the '179 patent. Merial had also asked the office to re-examine those claims during the summer of 2012.

GTG said today that USPTO has determined the patentability of claims 1-18 and 26-32 of the '179 patent, and no amendments have been made to the patent.

On Sept. 5, Merial filed another request for USPTO to re-examine the '179 patent. The office is currently reviewing the request, GTG said.

In a statement, GTG CEO Alison Mew said, "Once again, the successful resolution of this, the third re-examination of one of our key patents, reinforces the strength of the company’s non-coding patent portfolio. With the removal of what some potential licensees have apparently used as a reason to delay settlement discussions, we hope that such negotiations will now resume in earnest, with further licenses to our technology then being granted."

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.